Distribution of the glutamate transporters GLT-1 (SLC1A2) and GLAST (SLC1A3) in peripheral organs by Berger, Urs V & Hediger, Matthias A
ORIGINAL ARTICLE
Urs V. Berger Æ Matthias A. Hediger
Distribution of the glutamate transporters GLT-1 (SLC1A2) and GLAST
(SLC1A3) in peripheral organs
Accepted: 26 June 2006 / Published online: 26 July 2006
 Springer-Verlag 2006
Abstract The glutamate transporters GLT-1 and
GLAST are widely expressed in astrocytes in the brain
where they fulﬁll important functions during glutama-
tergic neurotransmission. The present study examines
their distribution in peripheral organs using in situ
hybridization (ISH) and immunocytochemistry. GLAST
was found to be more widely distributed than GLT-1.
GLAST was expressed primarily in epithelial cells, cells
of the macrophage-lineage, lymphocytes, fat cells,
interstitial cells, and salivary gland acini. GLT-1 was
primarily expressed in glandular tissue, including mam-
mary gland, lacrimal gland, and ducts and acini in sal-
ivary glands, but also by perivenous hepatocytes and
follicular dendritic cells in spleen and lymph nodes. The
ﬁndings demonstrate that, although expressed by the
same cells in the brain, these two glutamate transporters
have diﬀerent distribution patterns in peripheral tissues
and that they fulﬁll glutamate transport functions apart
from glutamatergic neurotransmission in these areas.
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Introduction
The GLT-1 (SLC1A2, also known as EAAT2) and
GLAST (SLC1A3, also known as EAAT1) are two
widely expressed glutamate transporters in the brain.
They belong to the ‘‘solute carrier 1’’ (SLC1) family of
solute transporters that also include the glutamate
transporters EAAC1 (SLC1A1 also known as EAAT3),
EAAT4 (SLC1A6), and EAAT5 (SLC1A7), as well as
the ‘‘system ASC’’ amino acid transporters, called
ASCT1 (SLC1A4) and ASCT2 (SLC1A5) (for a recent
review, see Kanai and Hediger 2004). GLT-1 and
GLAST remove glutamate from the brain extracellular
ﬂuid through co-transport of one glutamate molecule
with three sodium ions and one proton ion, as well as the
counter-transport of one potassium ion (Kanai and
Hediger 2004). Responsible for most of the glutamate
uptake in the brain, they fulﬁll a crucial role in gluta-
matergic neurotransmission by removing glutamate
from the synaptic cleft and keeping extracellular gluta-
mate below neurotoxic levels. Originally, GLT-1 and
GLAST expressions had both been localized to astro-
cytes in the brain (Kanai and Hediger 2004). GLAST is
most strongly expressed in the Bergmann glia, whereas
GLT-1 is strongest in astrocytes in cerebral cortex and
hippocampus. However, most astrocytes express both
transporters, and their protein localization on the plas-
ma membrane is similar (Kanai and Hediger 2004).
More recent studies indicate that there is expression
of these two glutamate transporters beyond astrocytes.
For example, GLT-1 mRNA and protein have been
found in subgroups of neurons in forebrain, and a cur-
rent theory is that GLT-1 represents the long-sought
presynaptic glutamate transporter that removes gluta-
mate from the synaptic cleft after release (Chen et al.
2004). GLT-1 is also expressed in a select group of ta-
nycytes in the third ventricle, as well as in pineal and
pituitary gland (Berger and Hediger 2001). GLAST
expression has been demonstrated in ependymal cells, in
circumventricular organs such as the subfornical organ
and the organum vasculosum of the lamina terminalis,
as well as in the meninges and the pituitary gland
(Berger and Hediger 2000).
When GLT-1 and GLAST were ﬁrst isolated, initial
Northern analyses indicated a primary expression only
in the central nervous system. However, more detailed
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studies have uncovered that GLT-1 and GLAST
expressions are by far not restricted to the central
nervous system alone. GLAST expression has previously
been reported in the cochlea, pituitary gland, placenta,
pancreas, breast, and bone, whereas, GLT-1 expression
has been described in placenta, pancreas, bone, liver,
muscle, ovary, testis, and kidney (Tanaka 1993; Arriza
et al. 1994; Kawakami et al. 1994; Kirschner et al. 1994;
Li et al. 1994; Shashidharan et al. 1994; Furness and
Lehre 1997; Mason et al. 1997; Utsunomiya-Tate et al.
1997; Martinez-Lopez et al. 1998; Matthews et al. 1998;
Redecker and Pabst 2000; Howell et al. 2001; Furness
et al. 2002; Howell et al. 2003; Redecker et al. 2003;
Mason 2004). Most of these studies presented evidence
for expression of GLT-1 and GLAST using Northern
blotting or PCR reactions. When anatomical analysis
using immunostaining was performed, such as in
placenta, bone, or testis (Mason et al. 1997; Matthews
et al. 1998; Redecker et al. 2003), the localizations of
GLT-1 and GLAST were not associated with nerve
terminals, suggesting that GLT-1 and GLAST fulﬁll
additional roles in these peripheral organs, most likely
related to the use of transported glutamate for metabolic
purposes. In the present study, we have performed an in-
depth analysis of the distribution of GLT-1 and GLAST
outside the brain to identify the areas and cell types that
express these transporters in the periphery. Adjacent
sections were hybridized to mRNA probes for GLT-1
and GLAST and processed for non-isotopic in situ
hybridization (ISH). Once the expression of mRNA was
established in speciﬁc cell types, immunostaining for
GLT-1 and GLAST was performed to demonstrate the
presence of glutamate transporter protein.
Materials and methods
Animals
Male and female Sprague-Dawley rats (200–250 g, three
per gender) from Takoma Farms were used for this
study. The animals were housed in the animal care
facility on site prior to the collection of the tissues. This
research was approved by the Brigham and Women’s
Hospital Institutional Animal Care and Use Committee
and fully conforms to the ‘‘Principles of Laboratory
Animal Care of the National Institutes of Health’’ (NIH
publication no. 86-23, revised 1985). All results
presented were observed in at least three independent
experiments.
Tissue preparation
Rats were anesthetized with an i.p. injection of pento-
barbital (50–100 mg/kg) and then sacriﬁced by decapi-
tation. Organs (liver, kidney, thymus, salivary glands,
testis, prostate, urethra, spleen, ovaries, urinary bladder,
tongue, lymph nodes, heart, and mammary glands) were
dissected and immediately frozen by placing in dry-ice
cooled isopentane at 30C. Organs were stored in
50 ml tubes in the 80C freezer for 1 week to 3 months
before they were sectioned in a Leica cryostat at 10 lm
thickness. Sections were placed on Superfrost Plus
microscope slides (Fisher, Atlanta, GA, USA), and the
slides were stored in a slide box in the 20C freezer for
1 day to 3 months before processing.
In situ hybridization
Non-isotopic ISH was performed using digoxigenin-la-
beled cRNA probes and alkaline phosphatase detection
as described (Berger and Hediger 1998). The microscope
slides with the unﬁxed sections were adjusted to room
temperature for 5 min, and then ﬁxed in freshly pre-
pared, ice-cold 4% paraformaldehyde in 0.1 M phos-
phate buﬀer (pH 7.4) for 15 min by immersion. Slides
were washed three times for 5 min in 0.1 M phosphate-
buﬀered saline, and then acetylated by immersing in
1.4% triethanolamine (Sigma, St Louis, MO, USA) to
which acetic anhydride was added to 0.5% followed by
stirring for 10 min. Hybridization was performed in
slide mailers by total immersion in hybridization buﬀer
that contained 50% formamide, 5 · single-strength
citrate (SSC), 2% blocking reagent (Roche Applied
Science, Indianapolis, IN, USA), 0.02% SDS, 0.1%
sarcosine, and approximately 100 ng/ml of cRNA
probe. Sections were hybridized at 68C over 72 h with
probes against rat GLT-1 (1.6 kb, nucleotides 136–1,763
of the Kanner clone) or against rat GLAST (1.8 kb,
nucleotides 58–1,900 of a PCR fragment, Berger and
Hediger 2000). Washing steps included incubations in
2 · SSC and 0.2 · SSC at 68C. Sections were incu-
bated at room temperature in 1% blocking reagent in
maleic acid buﬀer, then in alkaline phosphatase-conju-
gated anti-digoxigenin Fab fragments (1:5,000 dilution,
1 h, Roche), and developed for 18 or 42 h with BCIP/
NBT substrate (Kierkegard and Perry Laboratories,
Gaithersburg, MD, USA). Sections were rinsed several
times in 100 mM Tris, 150 mM NaCl, 20 mM EDTA
pH 9.5, and coverslipped with glycerol gelatin (Sigma).
Control sections were incubated in an identical concen-
tration of the sense probe transcript. Photographs were
taken using a Nikon E600 microscope and a SPOT
digital camera. Image plates were assembled using
Adobe Photoshop 6.0 software on a Macintosh ibook
600 mHz. All results presented were observed in at least
three independent experiments.
Immunohistochemistry
Immunostaining was performed on frozen sections that
were adjacent to those used for ISH, using peptide-
puriﬁed rabbit antibodies against GLAST (anti-A522,
antibody no. 141, animal number 68488, August 24,
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1995) and GLT-1 (anti-B12, antibody no. 291, animal
number 26970, February 3, 1998) (Haugeto et al. 1996).
The antibodies were provided by Dr. N.C. Danbolt,
University of Oslo, Norway. Slides carrying the frozen
sections were adjusted to room temperature for 5 min
and then ﬁxed in neutral buﬀered 10% formalin at room
temperature for 15 min (Sigma). Slides were then
incubated in blocking solution (1% normal goat serum,
0.1 % triton X-100 in 20 mM phosphate-buﬀered saline)
for 1 h, before they were incubated with the GLAST or
GLT-1 antisera at a dilution of 1:2,000 in blocking
solution overnight (18 h) at room temperature.
Following three washes for 5 min each, bound
antibodies were visualized through incubation for 2 h at
room temperature with a CY3-conjugated goat
anti-rabbit secondary antibody (1:200, Jackson Immu-
noResearch Laboratories, West Grove, PA, USA,
catalog no. 111-165-003) in 1% normal goat serum in
phosphate-buﬀered saline. Subsequently, slides were
washed three times for 15 min each in phosphate-buf-
fered saline and then coverslipped using Vectamount
(Vector Laboratories, Burlingame, CA, USA). Controls
included incubation without primary antibodies.
Photographs were taken using a Nikon E600 microscope
and a SPOT digital camera, and assembled using Adobe
Photoshop 6.0 software on a Mac ibook 600 MHz.
Results
The speciﬁcities of the GLT-1 and GLAST RNA probes
used have been established in several previous studies.
They produce distinct labeling patterns in the brain
(Berger and Hediger 1998, 2000, 2001) as well as in
peripheral organs. In most tissues, one probe served as a
control for the other since GLT-1 and GLAST were
mostly localized to diﬀerent cell types. The speciﬁcities
of the GLT-1 and GLAST antibodies used in this study
have also been demonstrated previously (Lehre et al.
1995). Antibodies against both transporters produced
selective staining in numerous tissues and cell types. The
GLAST staining diﬀered in all cases from the GLT-1
staining, demonstrating that the secondary antibody did
not produce any background. Because of the large
amount of data, we decided to present results as pictures
only where signals for both the mRNA and the protein
for one or both transporters could be demonstrated. In
some tissues, signals could only be shown with either in
situ labeling or immunostaining, but not both. This is
likely due to a lack of detection sensitivity either for the
in situ detection or the immunostaining. However, since
only one type of GLAST or GLT-1 antiserum was used
in this study, the possibility cannot be ruled out that any
immunostaining observed without concurrent in situ
labeling may represent a cross-reaction with another
unknown antigen.
The results for the GLT-1 and GLAST ISH and
immunostaining are presented in Figs. 1, 2, 3, 4, and 5
and summarized in Table 1. In most Figures, GLAST
mRNA labeling and GLAST protein staining are shown
in columns 1 and 2, respectively, and GLT-1 mRNA
labeling and GLT-1 protein staining are shown in col-
umns 3 and 4. Most rows show adjacent sections of the
same tissue. In general, GLAST mRNA and protein was
found to be widely expressed in peripheral tissues in a
number of epithelia and some other speciﬁc cell types. In
contrast, GLT-1 mRNA and protein expression was
found in fewer tissues and usually not in epithelia-
forming cells. Whereas GLAST and GLT-1 may be ex-
pressed in the same organ, they are usually localized to
diﬀerent cell types.
Epithelia
Strong epithelial expression of GLAST mRNA and
protein was observed in tongue, kidney, urinary bladder,
ovary, prostate gland, and urethra. In the tongue,
GLAST mRNA (Fig. 1a) and protein (Fig. 1b) was
restricted to the basal cell layer of the epithelium out-
lining membranes (insert in Fig. 1b), suggesting a
membranous localization. GLT-1 message could not be
demonstrated in tongue (Fig. 1c). However, a relatively
faint GLT-1 immunosignal was present in the epithelium
more superﬁcial to where the GLAST signal was local-
ized (Fig. 1d). At the light microscope level, this im-
munosignal appeared relatively diﬀuse, making its
precise cellular localization unclear. Since no GLT-1
mRNA could be detected at the same location, the
GLT-1 immunostaining in the tongue epithelium may be
non-speciﬁc.
In the kidney, GLAST mRNA and protein were
found in the transitional surface epithelium of the renal
pelvis (Fig. 1e, f) and in the macula densa portion of the
distal convoluted tubules (Fig. 1i, j). Again, the immu-
nostaining highlighted the membranes of the epithelial
cells (insert in Fig. 1f). No signiﬁcant expression of
GLT-1 mRNA or protein staining was detected in the
transitional epithelium (Fig. 1g, h). GLT-1 protein, but
not mRNA, staining was observed in the glomeruli
(Fig. 1k, l). However, the intensity of this glomerular
GLT-1 staining was markedly higher than the GLT-1
staining in other organs, making it likely that it repre-
sents crossreactivity with another unrelated protein. The
transitional epithelium is continuous with the lining of
the ureter and the lining of the urinary bladder.
Consistent with this, the GLAST mRNA and protein
staining was also present in the epithelium in urinary
bladder (Fig. 1m, n). Again, the protein immunostaining
outlined the membrane of the epithelial cells, primarily
in the basal cell layer. No GLT-1 mRNA or protein
labeling was seen in urinary bladder (Fig. 1o, p).
In the ovary, GLAST mRNA and protein labeling
was detected in the epithelia of corpus luteum, as well as
in theca cells in various stages of development (Fig. 2a,
b, e, f). Also, GLAST immunostaining was apparent in
the germinal surface epithelium covering the ovary
(Fig. 2b). No GLT-1 mRNA or protein labeling was
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observed in the ovary (Fig. 2c, d, g, h). In the prostate
gland, GLAST mRNA and protein were present in the
epithelial cell layer (Fig. 2i, j). The GLAST immuno-
staining clearly outlined the lateral and basal mem-
branes and was fainter in the apical membranes. The
basal lamina was also immunopositive. No mRNA
labeling for GLT-1 was observed in the prostate epi-
thelium (Fig. 2k), but the basal lamina between the
epithelial layers was immunopositive as well (Fig. 2l).
The basal lamina staining was not observed in controls
Fig. 1 In situ hybridization analysis of mRNA expression (ﬁrst and
third columns) and immunocytochemical analysis of protein
expression (second and fourth columns) for GLAST (left two
columns) and GLT-1 (right two columns) in the tongue (a–d), in
the transitional surface epithelium of kidney (e–h), in kidney cortex
near glomeruli (i–l), and in the urinary bladder (a–d, m–p). GLAST
mRNA and protein is expressed by cells in the basal layer of the
tongue epithelium (arrows, a, b). The insert in b shows the
membrane staining at higher magniﬁcation. GLT-1 mRNA was
not found in tongue (c), but a weak GLT-1 protein staining was
apparent in the epithelium more superﬁcial to the GLAST labeled
cells (arrow, d). In kidney, GLAST expression was found in the
transitional surface epithelium of the renal pelvis (arrows, e, f, and
insert in f) and in the macula densa portion of thick ascending
limbs (arrows, i, j, g: glomeruli). No GLT-1 labeling was seen in the
surface epithelium (g, h). Glomeruli (g and l) were strongly stained
for GLT-1, but showed no GLT-1 mRNA labeling (k). The basal
cell layer in urinary bladder epithelium showed mRNA and protein
labeling for GLAST but not GLT-1 (m–p, only epithelium and
subepithelial connective tissues are shown). Magniﬁcation bars:
50 lm
598
without primary antibody, but the lack of GLT1 mRNA
labeling suggests potential non-speciﬁc labeling. The
epithelium of the prostatic urethra is also labeled for
GLAST mRNA and GLAST protein (Fig. 2m, n), but
not GLT-1 mRNA or protein (Fig. 2o, p).
Lymphatic organs
Both GLAST and GLT-1 mRNA and protein labeling
was observed in lymphatic organs such as spleen, lymph
nodes, and thymus. In thymus, strong GLAST mRNA
Fig. 2 In situ hybridization analysis of mRNA expression (ﬁrst and
third columns) and immunocytochemical analysis of protein
expression (second and fourth columns) for GLAST (left two
columns) and GLT-1 (right two columns) in the corpus luteum of
ovary (a–d), and the theca cells of ovary (e–h), the prostate (i–l),
and the urethra (m–p). In the ovary, GLAST mRNA and protein
labeling was found in the epithelium of corpus luteum (arrows, a,
b). The surface membrane of the ovary also showed positive
GLAST immunostaining (arrowheads, b) Theca cells in the ovary
were positively labeled for GLAST mRNA and protein (arrows, e,
f). No GLT-1 labeling was found in the ovary. GLAST mRNA and
protein was expressed in the epithelial cell layer of the prostate
(arrows, i, j) and the prostatic urethra (arrows, m, n). In urinary
bladder and urethra, the basal cell layer of the epithelium was
GLAST-positive. In prostate, the GLAST protein staining
appeared basolateral (j). No GLT-1 mRNA or protein labeling
was found in the epithelia of prostate or urethra (k, l, o, p). Only
the basal lamina below the epithelial cell layer in prostate was
immuno-positive for GLT-1 (arrow, l). Magniﬁcation bar: 50 lm
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and protein labeling was present in cells scattered
throughout cortex and medulla (Fig. 3a, b). Based on
their dendritic shape, these GLAST-positive cells are
likely antigen-presenting cells (insert in Fig. 3b). No
clear GLT-1 mRNA labeling or protein staining was
distinguished in thymus (Fig. 3c, d).
In the spleen, GLAST mRNA labeling and protein
immunostaining was widespread in red pulp and more
Fig. 3 In situ hybridization analysis of mRNA expression (a, c, e,
g, i, k) and immunocytochemical analysis of protein expression (b,
d, f, h, j, l, m–p) for GLAST (a, b, e, f, i, j, m–p) and GLT-1 (c, d, g,
h, k, l) in the thymus (a–d), the spleen (e–h), and a lymph node near
the salivary glands (i–l, m–p). GLAST mRNA and protein labeling
was found in scattered dendritic cells in thymus cortex and medulla
(a, b, insert in b). No labeling for GLT-1 was discerned in the
thymus. In the spleen, GLAST mRNA and protein staining was
widespread in red pulp, and more restricted in the germinal centers
of white pulp (GC). GLAST immunostaining was also apparent in
the surface membrane covering the spleen (arrowheads, f). GLT-1
mRNA and protein labeling was present in follicular dendritic cells
in the germinal centers (arrow, g, h). In lymph node, GLAST
mRNA and protein staining was also widespread in cortex and
medulla areas, and more restricted in the germinal centers (GC) (i,
j). Some areas of cortex showed widespread immunostaining of
cells that appeared cuboidal in shape (m, and at higher magniﬁ-
cation in n), suggesting they are lymphocytes. Other areas of cortex
showed very little labeling (not shown). In the medulla, the
GLAST-positive cells appeared dendritic in shape (o, and higher
magniﬁcation in p), suggesting antigen-presenting cells. Magniﬁ-
cation bars: 50 lm for all pictures except insert in b, m, and n,
15 lm for insert in b, m, and n
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Fig. 4 In situ hybridization analysis of mRNA expression (ﬁrst and
third columns) and immunocytochemical analysis of protein
expression (second and fourth columns) for GLAST (left two
columns) and GLT-1 (right two columns) in the mammary gland
(a–d), the intraorbital lacrimal gland (e–h), the submandibular
salivary gland (i–l), and the parotid salivary gland (m–n). In the
mammary gland, GLAST mRNA is expressed in scattered
interstitial cells (arrows, a) that form a reticular network which is
stained by the GLAST antiserum (arrow, b). GLT-1 mRNA and
protein labeling is expressed in the glandular cells (c, d). In the
lacrimal gland, no labeling for GLAST mRNA or protein was
found (e, f). In contrast, the secretory lacrimal gland cells express
GLT-1 mRNA (arrows, g) and GLT-1 protein (arrow, h). In the
submandibular gland, GLAST mRNA (i) and GLAST protein (j) is
expressed by acini but not by striated (arrowheads) or granular
(arrows) ducts (i, j). The GLAST staining is localized to the
basolateral membranes of the acini (j, and arrowhead in insert in j,
asterisks: lumen of acinus). Weak GLT-1 mRNA labeling is found
in acini and striated (arrowheads) and granular (arrows) ducts (k).
However, GLT-1 protein staining was only pronounced in the
ducts (l). Granular ducts showed intense staining of the luminal
surface (arrows), whereas, staining of striated ducts was moderate,
and present both on membranes and in the cytoplasm (arrowheads).
The insert in l shows a higher magniﬁcation of a granular duct with
pronounced surface staining (arrowhead), the asterisks point to
cytoplasmic staining of the duct cells. In the parotid gland, no
appreciable GLAST mRNA labeling was present (m); yet, GLAST
protein staining of basolateral membranes was widespread (n, and
insert in n, asterisks: acinus lumen, arrowhead: stained acinus
membrane). Weak GLT-1 mRNA labeling was present in the ducts
of parotid gland (asterisks, o), but no labeling was observed in the
acini. GLT-1 protein staining was found in both ducts (asterisks, p)
and in the acini (p). The insert in p shows a higher magniﬁcation of
a striated duct (asterisks) and the stained basal acinus membranes
(arrowhead). Magniﬁcation bars: 50 and 15 lm for inserted pictures
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restricted in white pulp (Fig. 3e, f). The shape of the
GLAST-positive cells was again dendritic. The GLAST
antibody also stained the surface membrane of the
spleen (Fig. 3f). GLT-1 mRNA labeling was present in a
cluster of cells in the germinal centers within the white
pulp (Fig. 3g). Likewise, GLT-1 immunostaining was
primarily restricted to the cells in the germinal center
(Fig. 3h).
A very similar labeling pattern was seen in salivary
gland lymph nodes: widespread labeling for GLAST in
cortex and medulla, and relatively restricted labeling for
GLT-1 in germinal centers (Fig. 3i–l).
GLAST mRNA and protein appeared to be localized
in more than one cell type of the lymph node. In the
bottom row of Fig. 3, low and high power views of
GLAST immunostaining in lymph node cortex
(Fig. 3m, n) and medulla (Fig. 3o, p) are shown. In
certain parts of the cortex, GLAST was expressed in a
great number of cells (Fig. 3m, n), while in other parts of
the cortex, GLAST was expressed only in a few cells (not
shown), suggesting GLAST expression in certain lym-
phocytes. In medullary areas, GLAST positive cells were
somewhat less abundant and had a diﬀerent morphol-
ogy. In comparison to the relatively cuboidal appear-
ance of GLAST positive cells in cortex (Fig. 3m, n), the
scattered GLAST positive cells in the medulla had more
dendrites (Fig. 3o, p), suggesting antigen-presenting
cells.
Glands
Glandular tissues such as mammary gland, orbital lac-
rimal gland, and salivary glands expressed both GLAST
Fig. 5 In situ hybridization analysis of mRNA expression (ﬁrst and
third columns) and immunocytochemical analysis of protein
expression (second and fourth columns) for GLAST (left two
columns) and GLT-1 (right two columns) in the liver (a–d), in
adipose cells from a fat pad near kidney medulla (e–h), and in
interstitial connective tissue near salivary glands (i–l). GLAST
expression was not observed in liver (a, b) apart from some
interstitial cells near blood vessels (not shown). In contrast, GLT-1
mRNA and protein were strongly expressed by perivenous
hepatocytes (c, d, v: vein). GLAST mRNA and protein was
expressed by adipose cells in a fat pad near kidney medulla (e, f)
whereas GLT-1 was not (g, h). GLAST mRNA and protein
labeling was observed in interstitial cells in connective tissue [from
salivary gland complex (arrows, i, j)]. No GLT-1 labeling was
present in interstitial tissue (k, l). Magniﬁcation bar: 50 lm
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and GLT-1 transporters, but in diﬀerent cell types. In
the mammary gland (Fig. 4a), GLAST mRNA labeling
was observed in connective tissue cells in between the
tubuloalveolar glands. These cells form a network of
ﬁbers that is strongly immunopositive for GLAST
(Fig. 4b). In contrast, GLT-1 mRNA and protein
expression is found in the epithelial cells of the alveolar
glands (Fig. 4c, d).
In the orbital lacrimal gland, GLAST mRNA or
protein labeling was not found (Fig. 4e, f). GLT-1
mRNA and protein, however, were present in the
secreting cells (Fig. 4g, h). The GLT-1 immunostaining
appeared cytoplasmatic at the light microscope level.
In the salivary glands, both GLAST and GLT-1
expression were observed. In the submandibular gland,
weak GLAST mRNA labeling was present in the
secretory acini, but not in the striated or granular ducts
(Fig. 4i). GLAST immunostaining highlighted the ba-
solateral membranes of the acini and was absent in ducts
(Fig. 4j). The insert in Fig. 4j highlights the basolateral
acinar GLAST staining. GLT-1 mRNA labeling was
also relatively weak and was observed in acini, striated
and granular ducts (Fig. 4k). GLT-1 protein staining
was strongest in the luminal surface of the granular
ducts (arrowheads, Fig. 4l, and insert in 4l). Less intense
GLT-1 staining was also seen in striated ducts (arrows,
Fig. 4l), but no clear signals were found in the acini
membranes.
In the parotid gland, no GLAST mRNA labeling
could be detected (Fig. 4m), but GLAST immuno-
staining was present in the acini membranes (Fig. 4n).
Again, the GLAST immunostaining was most pro-
nounced in the basolateral membranes of the acini (in-
sert in Fig. 4n). Weak GLT-1 mRNA labeling was
found in parotid gland ducts, but no labeling appeared
present in the acini (Fig. 4o). GLT-1 immunostaining, in
contrast, was present in the striated ducts, and also in
the abluminal membrane of the acini (Fig. 4p). The in-
sert in Fig. 4p highlights the GLT-1 staining in striated
ducts (asterisks), and in the acini membrane (arrow-
head).
Other organs
In the liver, no GLAST mRNA or protein labeling was
found in hepatocytes (Fig. 5a, b). In contrast, strong
GLT-1 mRNA and protein labeling was found in peri-
venous hepatocytes (Fig. 5c, d). The GLT-1 antiserum
labeled the membranes of the hepatocytes. A few cells
were positive for GLAST mRNA and protein in inter-
stitial tissue such as around major blood vessels in liver
(not shown).
Strong GLAST mRNA and protein staining was
found in fat cells, such as in the adipose tissue near the
kidney papilla (Fig. 5e, f) or other areas. The antiserum
staining outlined the membranes of the adipose cells. No
GLT-1 labeling was found in these fat cells (Fig. 5g, h).
Positive labeling for GLAST mRNA and protein was
also observed in interstitial cells in connective tissue
surrounding salivary glands (Fig. 5i, j). Similar to the
labeled cells in the mammary gland, GLAST mRNA
labeling was restricted to the cytoplasm near the nucleus,
whereas the GLAST protein staining was widely present
in the network ﬁbers produced by these cells (Fig. 5j).
No GLT-1 labeling was present in these interstitial cells
(Fig. 5i, j).
Discussion
The present study identiﬁes the cellular distribution
patterns for the glutamate transporters GLT-1 and
GLAST in peripheral tissues. In most tissues analyzed,
previous studies had not performed anatomical locali-
zation of the transporter expression. Interestingly, GLT-
1 and GLAST are both expressed by the same astrocytic
cells in the central nervous system (Kanai and Hediger
2004), but they appeared to be rarely co-localized in the
same cells in the periphery. GLAST expression was most
often seen in epithelial cells such as in the tongue, uri-
nary bladder, ovaries, prostate gland, and urethra. In
Table 1 Summary of results found in peripheral tissues using in
situ hybridization (ISH) and immunoﬂuorescence (IF) for GLAST
and GLAST
GLAST GLT1
ISH IF ISH IF
Epithelia
Tongue + +  ±
Kidney, surface epithelium + +  
Macula densa + +  
Bladder + +  
Ovary + +  
Prostate gland + +  
Urethra + +  
Lymphatics
Thymus + +  ±
Spleen, red pulp + +  
White pulp + +  
Germinal center + + + +
Lymph node, cortex,
and medulla
+ +  
Germinal center + + + +
Glands
Mammary, epithelium   + +
Connective tissue cells + +  
Submandibular, acini + + + 
Ducts   + +
Parotid, acini  + + +
Ducts    +
Lacrimal   + +
Liver, hepatocytes   + +
Fat cells + +  
Connective tissue cells + +  
Capsular membranes (heart,
ovary, and spleen)
 +  
± Denotes presence or absence of staining or labeling. Note
widespread expression of GLAST in epithelia and lymphatic tissues
and of GLT-1 in glandular tissue
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contrast, GLT-1 expression was observed primarily in
glandular tissue, including mammary glands, salivary
glands, and lacrimal glands. Furthermore, GLAST
expression was also found in dendritic cells and lym-
phocytes of lymphoid organs, and interstitial cells and
fat cells throughout the body. GLT-1, on the other
hand, was found also in perivenous hepatocytes in liver
and in a distinct group of dendritic cells in spleen and
lymph node.
In contrast to the brain, where GLAST and GLT-1
are crucial players in glutamatergic neurotransmission,
GLAST and GLT-1 expressions in the peripheral organs
may play a role in glutamate uptake for metabolic
purposes or in the conversion of glutamate to glutamine.
In addition, the glutamate transporter expression in the
periphery may also be involved in paracrine cell com-
munication (see below). One exception to this is the
localization of GLAST in membranes of supporting cells
in the organ of Corti of the inner ear, where this trans-
porter likely contributes to the removal of glutamate
from the extracellular space following synaptic release
(Furness and Lehre 1997; Furness et al. 2002).
Our results indicate that GLAST may be involved in
the glutamate homeostasis in epithelial cell layers. The
distribution of GLAST in the epithelial tissues is remi-
niscent of the distribution of the water channel aqu-
aporin-3 (AQP3) (Matsuzaki et al. 1999). Like AQP3,
GLAST is expressed in basolateral membranes of the
transitional epithelium in kidney, ureter, urinary blad-
der, and urethra. In stratiﬁed portions of this epithelium,
GLAST, like AQP3, is expressed in the basal most layer
away from the urinary lumen, suggesting that its role is
likely related to the uptake of glutamate from the blood
side into the epithelial cells for nourishment, and not to
absorb glutamate from the urine. Similarly, in the ton-
gue, GLAST is expressed in the basal most cell layer of
the epithelium, suggesting a role in nourishment of the
epithelial cells. GLAST expression has also been dem-
onstrated in basal cells of rat taste buds (Lawton et al.
2000). In the ovary, the expression of GLAST by epi-
thelial cells in the corpus luteum and by theca cells may
suggest a role in the production of sex hormones. Apart
from some GLT-1-like immunoreactivities in the tongue
epithelium, GLT-1 was not observed in epithelial cells.
Another primary expression pattern of GLAST is in
macrophage-like cells. A number of studies have re-
ported the expression of GLAST in human microglial
cells and macrophages under various conditions (Noda
et al. 1999; Rimaniol et al. 2000, 2001; van Landeghem
et al. 2001; Chretien et al. 2002; Kugler and Schmitt
2003). Under culture conditions, though, GLAST
expression in microglia as assayed by PCR analysis was
low (Kondo et al. 1995). In the present study, we show
GLAST expression by cells in thymus, spleen, and
lymph nodes. Some of these GLAST-positive cells have
dendritic morphology suggesting that these cells are
antigen-presenting cells, possibly of the macrophage
lineage. The precise identity of these cells remains to be
elucidated by co-staining with cell type speciﬁc markers.
Both GLAST and GLT-1 expressions were found in
certain lymphocyte populations that did not appear to
overlap.
Other areas of observed GLAST expression include
fat cells and interstitial cells in connective tissue, where
glutamate uptake is likely required for an energy source
or metabolic precursor. Further, we observed GLAST-
like immunostaining in the capsules of urinary bladder,
ovary, heart (not shown), and spleen, reminiscent of its
expression in brain meninges (Berger and Hediger 2000).
The speciﬁcity of the capsular staining could not be
conﬁrmed by the presence of GLAST mRNA labeling,
possibly due to lack of detection sensitivity in the rela-
tively thin capsule cells. If conﬁrmed, the role of GLAST
expression by these capsules may possibly be related to
the use of glutamate as an osmolyte (Wagenfeld et al.
2002).
In contrast to GLAST, GLT-1 appears to have a
predominant expression in glandular tissue, such as
the mammary or the lacrimal glands. In the mammary
gland, a previous study has found expression of both
GLAST and GLT-1 mRNA and protein (Martinez-
Lopez et al. 1998). The precise cellular expression was
not determined, but it was found that the expression
of GLT-1 was constant in the physiological situations
studied, whereas GLAST expression was down-regu-
lated by fasting and up-regulated after refeeding.
GLAST was also reduced after weaning for 24 h and
returned to control values after resuckling. Our ﬁnd-
ings of GLT-1 expression by glandular cells and
GLAST expression by interstitial, connective tissue
cells is in agreement with these previous ﬁndings since
we only examined mammary glands from non-nursing
mothers.
In the salivary glands, expression for both trans-
porters was observed. In the submandibular and parotid
glands, GLAST was present in the basolateral mem-
branes of the acini, whereas, GLT-1 was expressed pri-
marily in the striated and glandular ducts in the
submandibular gland, and in the striated ducts and basal
acinar membranes in parotid gland. These localizations
suggest that glutamate transport is involved in the gen-
eration of saliva. GLT-1 and GLAST both co-transport
three Na ions, and counter transport one K ion during
glutamate uptake (Kanai and Hediger 2004). The strong
expression of GLT-1 protein in the luminal surface of
glandular ducts may suggest that active glutamate
transport from the lumen contributes to the Na reab-
sorption and the K secretion that is occurring in the
ducts to create hypotonic saliva (Nauntofte 1992). In the
acinar membranes, expression of GLT-1 and GLAST
may allow the accumulation of glutamate and the syn-
thesis of glutamate-rich proteins in the salivary glands
(Mirels et al. 1990).
A major function of the normal prostate gland is to
secrete large amounts of citrate (Costello and Franklin
2002). The prostate epithelial cells have adapted a spe-
cialized metabolic process of ‘‘net citrate production’’
which uses aspartate as a source for oxalacetate, a pre-
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requisite for the synthesis of citrate. The basolateral
membrane of these epithelial cells possesses high-aﬃnity,
androgen-regulated glutamate/aspartate transport
activity (Lao et al. 1993). Recently, EAAC1 has been
identiﬁed as one glutamate transporter responsible for
this aspartate transport (Franklin et al. 2006). Our data
suggest that GLAST also contributes to the basolateral
aspartate transport in prostate (Fig. 2f).
In the liver, GLT-1 mRNA and protein was strongly
expressed by perivenous hepatocytes. This ﬁnding is in
agreement with a recent study that demonstrated similar
GLT-1 immunostaining in perivenous hepatocytes and
an upregulation of GLT-1 by activation of the beta-
catenin (Cadoret et al. 2002). The authors of this study
have suggested that GLT-1 may be involved in the
proliferative response of the liver to beta-catenin by
providing glutamate to the cell as a precursor for glu-
tamine. An increase in GLT-1 expression in liver has
also been shown in growing versus non-growing lambs
(Howell et al. 2003).
Together with the glutamate transporter EAAC1,
GLT-1 likely contributes to the interorgan glutamine
ﬂux. All cells require glutamine as a nitrogen donor as
well as an energy source for cell-speciﬁc functions
(Welbourne et al. 2001). Muscle generates a major
portion of the total body pool of free amino acids while
the liver is the site of the urea cycle for disposal of
excessive nitrogenous waste. Free amino acids, in par-
ticular glutamine, are released from muscle into the
blood. In the liver, periportal hepatocytes absorb glu-
tamine and then ammonia is liberated with urea pro-
duction (Hediger and Welbourne 1999). A sinusoidal
glutamate exit mechanism releases glutamate, serving as
a major source of circulating glutamate. Glutamate may
be re-captured by glutamate transporter GLT-1 located
in the downstream perivenous hepatocytes (Fig. 5c, d).
Inside these cells, glutamate will be converted to gluta-
mine via glutamine synthetase. Glutamine will then be
released into the blood as part of the interorgan gluta-
mine ﬂux. The kidneys also partially contribute toward
the disposal of excessive nitrogen waste: ﬁltered gluta-
mine may be converted to glutamate either by the
phosphate-independent glutaminase (PIG) at the lumi-
nal surface, coupled to absorption of glutamate by
EAAC1 (Shayakul et al. 1997; Hediger 1999), or by the
intracellular phosphate-dependent glutaminase. Both
reactions produce ammonia, which is excreted by the
kidneys.
To summarize, our screen of peripheral glutamate
transporter expression has revealed widespread locali-
zation for GLAST and GLT-1. Although expressed by
the same astrocytes in the brain, GLAST and GLT-1
have mostly non-overlapping distribution in peripheral
cells, and are likely to contribute to a number of
peripheral functions.
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